Viewing Study NCT06318169


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2025-12-25 @ 8:16 PM
Study NCT ID: NCT06318169
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2024-03-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Sponsor: 89bio, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-13
Start Date Type: ACTUAL
Primary Completion Date: 2029-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-02
Completion Date Type: ESTIMATED
First Submit Date: 2024-03-13
First Submit QC Date: None
Study First Post Date: 2024-03-19
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-02
Last Update Post Date: 2025-12-04
Last Update Post Date Type: ESTIMATED